EyePoint (EYPT) Change in Cash (2010 - 2026)
EyePoint (EYPT) reported Change in Cash of -$24.1 million for Q1 2026, down 65.74% on a YoY basis from -$70.4 million in Q1 2025, and down 188.49% sequentially from $27.2 million in Q4 2025.
EyePoint (EYPT) Change in Cash (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Change in Cash data on file, last reported at -$24.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 65.74% year-over-year to -$24.1 million; the trailing twelve-month figure through Mar 2026 stood at -$7.4 million (up 95.99% YoY), and the FY2025 full-year result was $2.1 million, up 101.17% from the prior year.
- Change in Cash slipped to -$24.1 million in Q1 2026, from $27.2 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $148.2 million in Q4 2023 to a low of -$180.2 million in Q2 2024.
- A 5-year average of -$5.9 million and a median of -$6.8 million in 2022 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash jumped 631.23% in 2023 and tumbled 632.76% in 2024, its largest moves.
- Tracing EYPT's Change in Cash over 5 years: stood at $20.3 million in 2022, then jumped by 631.23% to $148.2 million in 2023, then sank by 86.59% to $19.9 million in 2024, then soared by 37.08% to $27.2 million in 2025, then sank by 188.49% to -$24.1 million in 2026.
- Business Quant data shows EYPT's Change in Cash at -$24.1 million in Q1 2026, $27.2 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -24.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.11 Mn |
| Dec 31, 2025 | 27.24 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | -14.02 Mn |
| Mar 31, 2025 | -14.55 Mn |
| Dec 31, 2024 | 19.87 Mn |
| Sep 30, 2024 | -10.94 Mn |
| Jun 30, 2024 | -180.24 Mn |
| Mar 31, 2024 | -10.25 Mn |
| Dec 31, 2023 | 148.23 Mn |
| Sep 30, 2023 | -6.56 Mn |
| Jun 30, 2023 | 33.83 Mn |
| Mar 31, 2023 | 10.13 Mn |
| Dec 31, 2022 | 20.27 Mn |
| Sep 30, 2022 | -6.77 Mn |
| Jun 30, 2022 | -19.41 Mn |
| Mar 31, 2022 | -77.05 Mn |
| Dec 31, 2021 | 58.88 Mn |
| Sep 30, 2021 | -7.92 Mn |
| Jun 30, 2021 | -10.95 Mn |